PCM
GRCL

PenderFund Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

PenderFund Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,570
Closed -$300K – 141
2023
Q4 		$300K Buy
+22,570
New +$300K 0.1% 71